Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Histogenics (HSGX) Competitors

Histogenics logo

HSGX vs. ZJYL, SMTI, INGN, LAKE, NTRB, APT, MLSS, COCH, RBOT, and CLGN

Should you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Jin Medical International (ZJYL), Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Nutriband (NTRB), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Envoy Medical (COCH), Vicarious Surgical (RBOT), and CollPlant Biotechnologies (CLGN).

Histogenics vs.

Histogenics (NASDAQ:HSGX) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.

In the previous week, Histogenics' average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company Overall Sentiment
Histogenics Neutral
Jin Medical International Neutral

40.4% of Histogenics shares are owned by institutional investors. 19.7% of Histogenics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Histogenics received 359 more outperform votes than Jin Medical International when rated by MarketBeat users.

CompanyUnderperformOutperform
HistogenicsOutperform Votes
359
71.66%
Underperform Votes
142
28.34%
Jin Medical InternationalN/AN/A

Jin Medical International has higher revenue and earnings than Histogenics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HistogenicsN/AN/A-$8.64M-$0.79-1.21
Jin Medical International$19.82M15.56$2.88MN/AN/A

Jin Medical International's return on equity of 0.00% beat Histogenics' return on equity.

Company Net Margins Return on Equity Return on Assets
HistogenicsN/A -34.96% 18.40%
Jin Medical International N/A N/A N/A

Histogenics has a beta of 3.1, indicating that its stock price is 210% more volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 16.24, indicating that its stock price is 1,524% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Histogenics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Jin Medical International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Histogenics and Jin Medical International tied by winning 4 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HSGX vs. The Competition

MetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$90.58M$9.32B$5.06B$8.43B
Dividend YieldN/A1.11%7.52%4.16%
P/E Ratio-1.2122.20131.9616.70
Price / SalesN/A35.571,683.8276.34
Price / CashN/A25.2237.1533.56
Price / Book-95.755.824.614.98
Net Income-$8.64M$181.29M$115.40M$224.69M

Histogenics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSGX
Histogenics
N/A$0.96
+1.1%
N/A+155.9%$90.58MN/A-1.2149Gap Down
ZJYL
Jin Medical International
N/A$2.00
-2.0%
N/A-76.3%$310M$20.13M0.00245Gap Down
SMTI
Sanara MedTech
2.0837 of 5 stars
$33.00
+0.8%
$44.00
+33.3%
+24.2%$284.63M$72.41M-42.3160Upcoming Earnings
Positive News
High Trading Volume
INGN
Inogen
2.522 of 5 stars
$8.73
-5.8%
$7.00
-19.8%
+63.0%$205.83M$326.65M-2.20834Upcoming Earnings
LAKE
Lakeland Industries
4.8627 of 5 stars
$18.59
-4.4%
$26.50
+42.5%
+31.4%$137.51M$137.74M77.461,750Gap Down
High Trading Volume
NTRB
Nutriband
0.7587 of 5 stars
$6.19
+0.3%
N/A+177.1%$68.75M$1.80M-7.6410Positive News
APT
Alpha Pro Tech
N/A$5.59
+0.4%
N/A+38.1%$62.46M$61.09M13.63120
MLSS
Milestone Scientific
2.2276 of 5 stars
$0.81
+1.3%
$1.25
+55.0%
-8.0%$62.29M$8.42M-11.5230Analyst Forecast
COCH
Envoy Medical
3.1101 of 5 stars
$2.65
+7.3%
$7.92
+198.7%
+142.9%$51.94M$302,000.000.0034Positive News
Gap Up
RBOT
Vicarious Surgical
1.9127 of 5 stars
$7.91
-2.5%
$11.33
+43.3%
-33.3%$46.65MN/A-0.763
CLGN
CollPlant Biotechnologies
1.9284 of 5 stars
$3.74
-0.5%
$11.00
+194.1%
-33.2%$42.83M$689,000.00-2.4370Negative News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:HSGX) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners